Taipei Veterans General Hospital, one of the medical institutions cooperating with Ever-Supreme, received approval from the Ministry of Health and Welfare on November 25, 2025, for "autologous immune cell (gamma-delta T)" cell therapy to treat "stage IV solid cancer". It provides related treatment courses for patients who meet the admission criteria. The indications are: stage IV solid cancer; cancer types: breast cancer, lung cancer, colorectal cancer, renal cell carcinoma, prostate cancer, and gastric cancer.
